The Campbell Score is a blood based means of assessing molecules believed to be associated with suicidal ideation and in some cases successful suicide. The current clinical trial will assess the Campbell Score in 3 groups: Group 1: 10 patients with no personal or family psychiatric history and no suicide attempts. Group 2: 10 patients with suicidal ideation (Hamilton Depression Rating Scale suicide item \>2) and reported low acquired capability for suicide (Acquired Capability for Suicide Scale \<20). Group 3: 10 patients with suicidal ideation (Hamilton Depression Rating Scale suicide item \>2) and reported high acquired capability for suicide (Acquired Capability for Suicide Scale \>60). The goal of the study is to confirm efficacy of Campbell Score in identifying patients with high suicidal ideation potential.
Study Type
OBSERVATIONAL
Enrollment
30
The Campbell Score is a blood based assessment of inflammatory and immunologically associated markers that is currently in development as a means of predicting suicidal ideations.
Therapeutic Solutions International
Oceanside, California, United States
RECRUITINGAssessment of Campbell Score
Campbell Score will be compared between healthy volunteers, patients with suicidal idea with low acquired capability for suicide, and patients with suicidal idea with high acquired capability for suicide.
Time frame: 1 week to compare the records with the Campbell Score
Assessment of Correlation between Campbell Score and Beck Scale for Suicidal Ideation
Campbell Score will be compared to scoring of patients on the Beck Scale for Suicidal Ideation
Time frame: 1 week to compare the records with the Campbell Score
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.